What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Advanced Research Center, Inc.

Home
United States
Anaheim, CA
Advanced Research Center, Inc.

Clinical research center dedicated to finding the most advanced treatment options

Visit our LinkedIn for more information:
https://www.linkedin.com/company/advanced-research-center-inc

Business Hours:
Mon-Fri: 9am-5pm

07/03/2025

Worried that a migraine won’t leave your child alone? We understand how tough it can be.
Visit our center to join a study evaluating the safety and effectiveness of a potential new treatment for migraines in children and adolescents.

To pre-qualify for this study, patients must:
-Be aged of 6 to 17 years old
-Experience between 1 and 14 migraine attacks per month with moderate to severe headaches in each of the 2 months prior to starting the study
-Be currently taking or have taken at least one oral medication for migraine treatment
-Have a Body Mass Index (BMI) of 20 kg/m² or higher but less than 135 kg/m²

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999 6688.

06/10/2025

Are COVID-19 related health issues affecting your child or loved one? We understand how tough it can be. Advanced Research Center is now looking for children aged 6 to 23 months with COVID-19 to participate in our clinical trials.

To pre-qualify for this study, patients must:
-Be 6 to 23 months of age.
-Be considered healthy based on medical history, physical examination, and clinical judgment.
-Have not received any COVID-19 vaccinations.
-Have not received systemic steroid treatments or therapies for COVID-19.
-Be available for the duration of the study, with their parent(s) or legal guardian reachable by telephone during the study period.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999 6688.

06/09/2025

Are you or someone close to you struggling with Generalized Anxiety Disorder (GAD)?

A clinical trial is currently enrolling adults between the ages of 18 and 65 who have been diagnosed with Generalized Anxiety Disorder (GAD).

To pre-qualify for this study, participants must:
-Be 18 to 65 years old with Generalized Anxiety Disorder (GAD)
-Be currently taking paroxetine, escitalopram, duloxetine, or venlafaxine ER for at least 8 weeks
-Not be currently experiencing a depressive episode
-Have no lifetime history of schizophrenia, schizoaffective disorder, bipolar I or II disorder, posttraumatic stress disorder, or developmental/cognitive disorders

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

05/28/2025

Are you feeling overwhelmed by postpartum depression (PPD)?
A clinical trial is now enrolling adult women aged 18–45 who are currently experiencing postpartum depression.

To pre-qualify for this study, participants must:
-Be a female between 18 and 45 years old
-Have started experiencing symptoms of depression during or shortly after pregnancy
-Not be currently pregnant
-Be within 9 months postpartum
-Be willing to stay inpatient for 3 nights

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

05/05/2025

Do you or someone you know have psychosis associated with Alzheimer’s disease (AD)?
Advanced Research Center is now looking for individuals aged 55 to 90 with symptoms related to Alzheimer’s disease to participate in our clinical trials.

To pre-qualify for this study, participants must:
-Be between 55 and 90 years old with symptoms associated with Alzheimer’s disease.
-Be able to move independently and have a study partner.
-Have a BMI between 18 and 40 kg/m².

Additional criteria may apply. Please contact our study team to confirm your eligibility at (714) 999 6688.

04/02/2025

Are you currently experiencing depression and diagnosed with Bipolar I or Bipolar II Disorder? Consider participating in an oral medication trial for adults aged 18 to 65 with depression at the Advanced Research Center today.

To pre-qualify for this study, you must:
-Be 18 to 65 years old.
-Have a diagnosis of Bipolar I or Bipolar II Disorder.
-Have been experiencing depression for at least 1 month but no longer than 12 months.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999 6688.

02/28/2025

Does your child have a diagnosis of autism spectrum disorder?

Find out if this study on a new investigational medication (“study drug”) for children and teenagers with autism can help. Join a study exploring potential treatments with a new class of investigational medication.

To pre-qualify for this study, patients must:
-Be 13 to 17 years old.
-Have a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD).
-Experience irritability, such as tantrums, aggression, yelling, or self-harming behavior.
-Have a body mass index (BMI) greater than the 5th percentile, according to CDC growth charts.
-Be currently an outpatient and expected to remain an outpatient for the duration of the study.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714)999 6688.

02/24/2025

Do you suffer from depression?
If you or someone you care for is living with major depressive disorder, you could qualify for the BHV 7000-305 study. This clinical trial is testing the efficacy and safety of a potential new medication for patients with major depressive disorder.

To pre-qualify for this study, patients must:
-Be an adult aged 18 to 75.
-Have been diagnosed with major depressive disorder (MDD) and experiencing persistent symptoms for 2 or more months.
-Currently be experiencing a major depressive episode (MDE) that has lasted for at least 2 months but less than 24 months.
-Have a Body Mass Index (BMI) between 18.0 and 35.0 kg/m².
-Discontinue MDD medication at least 14 days before the baseline visit.
Additional criteria may apply.
Please contact the study team to confirm your eligibility at (714) 999 6688

02/19/2025

Now enrolling teens with ADHD! Join a study exploring potential treatments using a new class of investigational medication.

To pre-qualify for this study, participants must:
-Be between 13 to 17 years old.
-Have a primary diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD).
-Be fluent in English and able to communicate effectively.
-Be willing and able to provide assent, along with parental/guardian consent.
-Be either naive to stimulant and/or non-stimulant ADHD medications or have been off them for at least 4 weeks.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999 6688.

01/15/2025

Do you struggle with bipolar disorder? Visit our center to join a study evaluating the efficacy and safety of an investigational drug for bipolar disorder in adults.

To pre-qualify for this study, patients must:
☑️Be aged 18 to 75 years with a primary diagnosis of bipolar I disorder.
☑️Be currently experiencing an episode of mania or mania with mixed features.
☑️Have been hospitalized voluntarily no more than 14 days before Screening (Visit 1) or admitted to an inpatient unit at Visit 1 with a primary diagnosis of mania.

Additional criteria may apply. To confirm eligibility or learn more, please contact the study team at (714) 999-6688.

01/02/2025

Concerned that ADHD is affecting your child’s daily life?

We understand how challenging it can be. Visit our center to join a study evaluating the safety and effectiveness of a potential new treatment for migraines in children and adolescents.

To pre-qualify for this study, patients must:
-Be between 4 years and 5 years 9 months old at the time of screening and considered medically healthy.
-Have a primary diagnosis of ADHD according to DSM-IV-TR criteria, confirmed with the Kiddie schedule for affective disorders and schizophrenia.
-Be participating in a structured group activity (e.g., preschool, kindergarten, sports, or child care) to assess symptoms and impairment in settings outside the home.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999-6688.

11/08/2024

Does your child suffer from depression due to bipolar disorder? Visit our center to join a study evaluating the efficacy and safety of an investigational drug for bipolar disorder in children and adolescents.

To pre-qualify for this study, patients must:
-Be aged 13 to 17 years old with a diagnosis of bipolar I or II disorder.
-Currently experiencing a major depressive episode (MDE) without psychosis that lasts between 1 and 12 months.
-Have a lifetime history of at least one manic or hypomanic episode.

Additional criteria may apply. To confirm eligibility or learn more, please contact the study team at (714) 999-6688.

Address

Anaheim, CA

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+17149996688

Website

https://arctrials.com/

Alerts

Be the first to know and let us send you an email when Advanced Research Center, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.